Greenberg Traurig Attorneys Speak at DeviceTalks West 2019
Greenberg Traurig, LLP attorneys Roman Fayerberg and Ginger Pigott will speak at DeviceTalks West, Dec. 9-10, 2019, at the Santa Clara Convention Center, Santa Clara, CA.
BOSTON, Dec. 10, 2019 /PRNewswire-PRWeb/ -- Greenberg Traurig, LLP attorneys Roman Fayerberg and Ginger Pigott will speak at DeviceTalks West, Dec. 9-10, 2019, at the Santa Clara Convention Center, Santa Clara, CA. Greenberg Traurig is a founding sponsor of DeviceTalks, and attorneys from the firm's global Life Sciences & Medical Technology Group have been featured speakers at every DeviceTalks conference since 2011.
On Dec. 9, from 4:00-4:45 p.m., Pigott, a shareholder and vice-chair of the firm's Pharmaceutical, Medical Device & Health Care Litigation Group in Los Angeles, will moderate the panel discussion, "Hot Topics: M&A, IP, and Products Liability Trends Impacting Medtech." Fayerberg, a patent attorney and shareholder in the firm's Intellectual Property (IP) Group in Boston, will serve as a panelist. They will be joined by Casper De Clercq, General Partner, Norwest Venture Partners and Marlon G. Housman, Senior Legal Director, Coronary and Structural Heart, Medtronic Inc.
The panel will focus on how Mergers & Acquisition (M&A) and Intellectual Property (IP), and products liability trends are impacting medtech. Attendees can expect to learn about:
- M&A and IP trends
- Products liability litigation – what every medtech company needs to know
DeviceTalks is the premier industry event for the medtech community fostering the exchange of ideas, insight, and technology among the pioneers of the medical technology industry and the engineering behind it.
About Greenberg Traurig's Life Sciences & Medical Technology Group: Greenberg Traurig's Life Sciences & Medical Technology Group advises clients ranging from start-ups to large multinational public companies to leading research institutions. The group's attorneys work closely with clients, providing innovative legal counsel to help them achieve their objectives – from discovery through commercialization and product marketing.
About Greenberg Traurig's Pharmaceutical, Medical Device & Health Care Litigation Practice: The Pharmaceutical, Medical Device & Health Care Litigation Practice is an integral part of the firm's 600-plus member national Litigation Practice. The team is nationally recognized for its dynamic courtroom presence, responsiveness to clients, and deep subject matter knowledge. Recent recognitions include national rankings for 2018 "Products Liability & Mass Torts" from Chambers USA Guide; national rankings for 2018 "Practice Liability & Mass Torts Defense: Pharmaceuticals and Medical Devices" from The Legal 500 United States; and being named the Products Liability/Mass Torts Litigation Department of the Year by The Daily Report in 2013 and from 2015-2017. In addition, Greenberg Traurig is recognized as a "Product Liability Litigation Standout" in the BTI Litigation Outlook 2018 published by BTI Consulting Group.
About Greenberg Traurig, LLP: Greenberg Traurig, LLP (GT) has approximately 2100 attorneys in 41 locations in the United States, Latin America, Europe, Asia, and the Middle East. GT has been recognized for its philanthropic giving, diversity, and innovation, and is consistently among the largest firms in the U.S. on the Law360 400 and among the Top 20 on the Am Law Global 100. Web: http://www.gtlaw.com, Twitter: @GT_Law.
SOURCE Greenberg Traurig, LLP
Share this article